Robbins Farley’s Boston Scientific BSX Stock Holding History

Robbins Farley’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.94K	Sell	186 -43,944	-100%	-$2.39M	﹤0.01%	120
2026 Q1	$2.77M	Buy	44,130 +1,591	+4%	+$127K	1.23%	38
2025 Q4	$4.06M	Sell	42,539 -49	-0.1%	-$4.8K	1.84%	27
2025 Q3	$4.16M	Buy	42,588 +5,066	+14%	+$525K	1.73%	28
2025 Q2	$4.03M	Buy	37,522 +442	+1%	+$44.7K	1.88%	27
2025 Q1	$3.74M	Buy	+37,080	New	+$3.73M	1.98%	23
2024 Q3	–	Sell	-15	Closed	-$1.16K	–	161
2024 Q2	$1.16K	Buy	+15	New	+$1.1K	﹤0.01%	137

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Robbins Farley's BSX Position: Q2 2026 in Review

Robbins Farley reduced its Boston Scientific (BSX) stake by 100% in Q2 2026, selling an estimated $2.39M and leaving 186 shares worth $7.94K. The position accounts for ﹤0.01% of the portfolio, ranked #120.

Robbins Farley first reported a position in BSX in Q2 2024 and has held it in 7 quarters since. The position peaked at $4.16M in Q3 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Robbins Farley held 186 shares of Boston Scientific worth $7.94K as of Q2 2026.
Robbins Farley sold 43,944 Boston Scientific shares in Q2 2026, an estimated $2.39M.
Boston Scientific made up ﹤0.01% of Robbins Farley's portfolio in Q2 2026, its #120 holding.
Robbins Farley first reported a position in Boston Scientific in Q2 2024 and has held it in 7 quarters since.
Robbins Farley's Boston Scientific position peaked at $4.16M in Q3 2025.
1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Robbins Farley's 13F filing for Q2 2026, filed 23 Jul 2026.